Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_151_библиотеки_им_акад_М_И_Перельмана
.pdf
Role of Neuromodulators in Regulation of the Tumor Microenvironment.. . 175
https://t.me/med1917
Datta M, Coussens LM, Nishikawa H, Hodi FS, Jain RK (2019) Reprogramming the tumor
microenvironment to improve immunotherapy: emerging strategies and combination therapies.
Am Soc Clin Oncol Educ Book 39:165–174. https://doi.org/10.1200/EDBK_237987
de Oliveira GA, Cheng RYS, Ridnour LA, Basudhar D, Somasundaram V, McVicar DW, Monteiro
HP, Wink DA (2017) Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal
cancers. Antioxid Redox Signal 26:1059–1077. https://doi.org/10.1089/ars.2016.6850
Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JCM,
Voorberg J, Pannekoek H, Horrevoets AJG (2006) KLF2 provokes a gene expression pattern
that establishes functional quiescent differentiation of the endothelium. Blood 107:4354– 4363.
https://doi.org/10.1182/blood-2005-08-3465
Delvalle NM, Fried DE, Rivera-Lopez G, Gaudette L, Gulbransen BD (2018) Cholinergic activa-
tion of enteric glia is a physiological mechanism that contributes to the regulation of gastroin-
testinal motility. Am J Physiol Gastrointest Liver Physiol 315:G473–G483. https://doi.org/10.
1152/ajpgi.00155.2018
Di Y-Z, Han B-S, Di J-M, Liu W-Y, Tang Q (2019) Role of the brain-gut axis in gastrointestinal
cancer. World J Clin Cases 7:1554–1570. https://doi.org/10.12998/wjcc.v7.i13.1554
Dinicola S, Morini V, Coluccia P, Proietti S, D’Anselmi F, Pasqualato A, Masiello MG,
Palombo A, De Toma G, Bizzarri M, Cucina A (2013) Nicotine increases survival in human
colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro 27:2256–2263. https://
doi.org/10.1016/j.tiv.2013.09.020
Dowling P, Hughes DJ, Larkin AM, Meiller J, Henry M, Meleady P, Lynch V, Pardini B,
Naccarati A, Levy M, Vodicka P, Neary P, Clynes M (2015) Elevated levels of 14-3-3 proteins,
serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients
diagnosed with colorectal cancer. Clin Chim Acta 441:133–141. https://doi.org/10.1016/j.cca.
2014.12.005
Duraker N, Sişman S, Can G (2003) The significance of perineural invasion as a prognostic factor in
patients with gastric carcinoma. Surg Today 33:95–100. https://doi.org/10.1007/
s005950300020
Eisenhofer G, Aneman A, Friberg P, Hooper D, Fåndriks L, Lonroth H, Hunyady B, Mezey E
(1997) Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol
Metab 82:3864–3871. https://doi.org/10.1210/jcem.82.11.4339
El-Salhy M (2005) Effects of octreotide, galanin and serotonin on a human gastric cancer cell line.
Oncol Rep 13:787–791
Eroglu E, Hallström S, Bischof H, Opelt M, Schmidt K, Mayer B, Waldeck-Weiermair M,
Graier WF, Malli R (2017) Real-time visualization of distinct nitric oxide generation of nitric
oxide synthase isoforms in single cells. Nitric Oxide 70:59–67. https://doi.org/10.1016/j.niox.
2017.09.001
Feldberg W, Lin RC (1950) Synthesis of acetylcholine in the wall of the digestive tract. J Physiol
111:96–118. https://doi.org/10.1113/jphysiol.1950.sp004467
Felton J, Hu S, Raufman J-P (2018) Targeting M3 muscarinic receptors for colon cancer therapy.
Curr Mol Pharmacol 11:184–190. https://doi.org/10.2174/1874467211666180119115828
Feng F, Yang J, Tong L, Yuan S, Tian Y, Hong L, Wang W, Zhang H (2011) Substance P
immunoreactive nerve fibres are related to gastric cancer differentiation status and could
promote proliferation and migration of gastric cancer cells. Cell Biol Int 35:623–629. https://
doi.org/10.1042/CBI20100229
Feng X-Y, Yan J-T, Li G-W, Liu J-H, Fan R-F, Li S-C, Zheng L-F, Zhang Y, Zhu J-X (2020)
Source of dopamine in gastric juice and luminal dopamine-induced duodenal bicarbonate
secretion via apical dopamine D2 receptors. Br J Pharmacol 177:3258–3272. https://doi.org/
10.1111/bph.15047
Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and infl
Trends Immunol 27:552–558. https://doi.org/10.1016/j.it.2006.10.004
ammation.
176 D. Chakroborty and C. Sarkar
https://t.me/med1917
Fleming MA, Ehsan L, Moore SR, Levin DE (2020) The enteric nervous system and its emerging
role as a therapeutic target. Gastroenterol Res Pract 2020:8024171. https://doi.org/10.1155/
2020/8024171
Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J
33:829–837, 837a–837d. https://doi.org/10.1093/eurheartj/ehr304
Furness JB, Callaghan BP, Rivera LR, Cho H-J (2014) The enteric nervous system and gastroin-
testinal innervation: integrated local and central control. Adv Exp Med Biol 817:39–71. https://
doi.org/10.1007/978-1-4939-0897-4_3
Ganguly S, Basu B, Shome S, Jadhav T, Roy S, Majumdar J, Dasgupta PS, Basu S (2010)
Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-
induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through
down-regulation of IGF-IR and AKT phosphorylation. Am J Pathol 177:2701–2707. https://
doi.org/10.2353/ajpath.2010.100617
Gáti T, Gelencsér F, Hideg J (1975) The role of adrenergic receptors in the regulation of gastric
motility in the rat. Z Exp Chir 8:179–184
Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug
development for functional GI disorders. Gastroenterology 132:397–414. https://doi.org/10.
1053/j.gastro.2006.11.002
Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, Validire P, Ingels A,
Cathelineau X, Fridman WH, Sautès-Fridman C (2019) The clinical role of the TME in solid
cancer. Br J Cancer 120:45–53. https://doi.org/10.1038/s41416-018-0327-z
Gomez-Flores R, Gutierrez-Leal I, Caballero-Hernández D, Orozco-Flores A, Tamez-Guerra P,
Tamez-Guerra R, Rodríguez-Padilla C (2021) Association of tyrosine hydroxylase expression in
brain and tumor with increased tumor growth in sympathectomized mice. BMC Res Notes
14:94. https://doi.org/10.1186/s13104-021-05507-w
Goodman JE, Hofseth LJ, Hussain SP, Harris CC (2004) Nitric oxide and p53 in cancer-prone
chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 44:3–9. https://
doi.org/10.1002/em.20024
Goswami S, Chakroborty D, Basu S, Frankel W, Sarkar C (2020) The dual regulatory role of
Neuropeptide Y in colon cancer. Cancer Res 80(16_Supplement):5168–5168
Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, Hayakawa N, Kajiyama G (1999)
Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of
gastric cancer patients. Clin Cancer Res 5:1411–1415
Goyal RK, Hirano I (1996) The enteric nervous system. N Engl J Med 334:1106–1115. https://doi.
org/10.1056/NEJM199604253341707
Guren MG (2019) The global challenge of colorectal cancer. Lancet Gastroenterol Hepatol
4:894–895. https://doi.org/10.1016/S2468-1253(19)30329-2
Hadjiconstantinou M, Neff NH (2008) Enhancing aromatic L-amino acid decarboxylase activity:
implications for L-DOPA treatment in Parkinson’s disease. CNS Neurosci Ther 14:340–351.
https://doi.org/10.1111/j.1755-5949.2008.00058.x
Hajiasgharzadeh K, Somi MH, Sadigh-Eteghad S, Mokhtarzadeh A, Shanehbandi D, Mansoori B,
Mohammadi A, Doustvandi MA, Baradaran B (2020) The dual role of alpha7 nicotinic
acetylcholine receptor in inflammation-associated gastrointestinal cancers. Heliyon 6:e03611.
https://doi.org/10.1016/j.heliyon.2020.e03611
Hansen MB (2003) The enteric nervous system I: organisation and classification. Pharmacol
Toxicol 92:105–113. https://doi.org/10.1034/j.1600-0773.2003.t01-1-920301.x
Hao MM, Young HM (2009) Development of enteric neuron diversity. J Cell Mol Med
13:1193–1210. https://doi.org/10.1111/j.1582-4934.2009.00813.x
Harrington AM, Lee M, Ong S-Y, Yong E, Farmer P, Peck CJ, Chow CW, Hutson JM, Southwell
BR (2010) Immunoreactivity for high-affi
human enteric nervous system. Cell Tissue Res 341:33–48. https://doi.org/10.1007/s00441-
010-0981-9
Harrison S, Geppetti P (2001) Substance p. Int J Biochem Cell Biol 33:555–576. https://doi.org/10.
1016/s1357-2725(01)00031-0
nity choline transporter colocalises with VAChT in
Role of Neuromodulators in Regulation of the Tumor Microenvironment.. . 177
https://t.me/med1917
Hering NA, Liu V, Kim R, Weixler B, Droeser RA, Arndt M, Pozios I, Beyer K, Kreis ME, Seeliger
H (2021) Blockage of cholinergic signaling via muscarinic acetylcholine receptor 3 inhibits
tumor growth in human colorectal adenocarcinoma. Cancers (Basel) 13:3220. https://doi.org/10.
3390/cancers13133220
Hernandez S, Rojas F, Laberiano C, Lazcano R, Wistuba I, Parra ER (2021) Multiplex immunoflu-
orescence Tyramide signal amplification for immune cell profiling of paraffin-embedded tumor
tissues. Front Mol Biosci 8:667067. https://doi.org/10.3389/fmolb.2021.667067
Höglund E, Øverli Ø, Winberg S (2019) Tryptophan metabolic pathways and brain serotonergic
activity: a comparative review. Front Endocrinol 10:158. https://doi.org/10.3389/fendo.2019.
00158
Holzer P, Reichmann F, Farzi A (2012) Neuropeptide Y, peptide YY and pancreatic polypeptide in
the gut-brain axis. Neuropeptides 46:261–274. https://doi.org/10.1016/j.npep.2012.08.005
Hondermarck H, Jobling P (2018) The sympathetic nervous system drives tumor angiogenesis.
Trends Cancer 4:93–94. https://doi.org/10.1016/j.trecan.2017.11.008
Huang H, Wu K, Ma J, Du Y, Cao C, Nie Y (2016) Dopamine D2 receptor suppresses gastric cancer
cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. Int
Immunopharmacol 39:113–120. https://doi.org/10.1016/j.intimp.2016.07.002
Huang J, Koulaouzidis A, Marlicz W, Lok V, Chu C, Ngai CH, Zhang L, Chen P, Wang S, Yuan J,
Lao X-Q, Tse SLA, Xu W, Zheng Z-J, Xie S-H, Wong MCS (2021) Global burden, risk factors,
and trends of esophageal cancer: An analysis of cancer registries from 48 countries. Cancers
(Basel) 13:E141. https://doi.org/10.3390/cancers13010141
Hyland NP, Cox HM (2005) The regulation of veratridine-stimulated electrogenic ion transport in
mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Br J Pharmacol 146:712–722.
https://doi.org/10.1038/sj.bjp.0706368
Hyland NP, Cryan JF (2010) A gut feeling about GABA: focus on GABA(B) receptors. Front
Pharmacol 1:124. https://doi.org/10.3389/fphar.2010.00124
Iwasaki M, Akiba Y, Kaunitz JD (2019) Recent advances in vasoactive intestinal peptide physiol-
ogy and pathophysiology: focus on the gastrointestinal system. F1000Res 8:1629. https://doi.
org/10.12688/f1000research.18039.1
Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685–693. https://doi.org/
10.1038/nm0603-685
Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K,
Emson PC, Moncada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A
92:4392–4396. https://doi.org/10.1073/pnas.92.10.4392
Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP (2016) Influence of tryptophan and serotonin
on mood and cognition with a possible role of the gut-brain Axis. Nutrients 8:E56. https://doi.
org/10.3390/nu8010056
Jeppsson S, Srinivasan S, Chandrasekharan B (2017) Neuropeptide Y (NPY) promotes
inflammation-induced tumorigenesis by enhancing epithelial cell proliferation. Am J Physiol
Gastrointest Liver Physiol 312:G103–G111. https://doi.org/10.1152/ajpgi.00410.2015
Joseph J, Niggemann B, Zaenker KS, Entschladen F (2002) The neurotransmitter gamma-
aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma
cells. Cancer Res 62:6467–6469
Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. CA Cancer J
Clin 71:264–279. https://doi.org/10.3322/caac.21657
Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582–598.
https://doi.org/10.1038/nrc.2016.73
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest
119:1420–1428. https://doi.org/10.1172/JCI39104
Kannen V, Bader M, Sakita JY, Uyemura SA, Squire JA (2020) The dual role of serotonin in
colorectal cancer. Trends Endocrinol Metab 31:611–
04.008
625. https://doi.org/10.1016/j.tem.2020.
178 D. Chakroborty and C. Sarkar
https://t.me/med1917
Karadayı N, Kandemır NO, Yavuzer D, Korkmaz T, Gecmen G, Kokturk F (2013) Inducible nitric
oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lym-
phatic metastasis. Diagn Pathol 8:151. https://doi.org/10.1186/1746-1596-8-151
Khalaf K, Hana D, Chou JT-T, Singh C, Mackiewicz A, Kaczmarek M (2021) Aspects of the tumor
microenvironment involved in immune resistance and drug resistance. Front Immunol
12:656364. https://doi.org/10.3389/fimmu.2021.656364
Kim M-S, Ha S-E, Wu M, Zogg H, Ronkon CF, Lee M-Y, Ro S (2021) Extracellular matrix
biomarkers in colorectal cancer. Int J Mol Sci 22:9185. https://doi.org/10.3390/ijms22179185
Kitlinska J, Kuo L, Abe K, Pons J, Yu M, Li L, Tilan J, Toretsky J, Zukowska Z (2006) Role of
neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing’s sarcoma growth. Adv Exp
Med Biol 575:223–229. https://doi.org/10.1007/0-387-32824-6_24
Kleinrok Z, Matuszek M, Jesipowicz J, Matuszek B, Opolski A, Radzikowski C (1998) GABA
content and GAD activity in colon tumors taken from patients with colon cancer or from
xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol
Pharmacol 49:303–310
Krantis A (2000) GABA in the mammalian enteric nervous system. News Physiol Sci 15:284–290.
https://doi.org/10.1152/physiologyonline.2000.15.6.284
Krüttgen A, Schneider I, Weis J (2006) The dark side of the NGF family: neurotrophins in
neoplasias. Brain Pathol 16:304–310. https://doi.org/10.1111/j.1750-3639.2006.00037.x
Kulkarni S, Ganz J, Bayrer J, Becker L, Bogunovic M, Rao M (2018) Advances in enteric
neurobiology: the “brain” in the gut in health and disease. J Neurosci 38:9346–9354. https://
doi.org/10.1523/JNEUROSCI.1663-18.2018
Kurnik-Łucka M, Pasieka P, Łączak P, Wojnarski M, Jurczyk M, Gil K (2021) Gastrointestinal
dopamine in inflammatory bowel diseases: a systematic review. Int J Mol Sci 22:12932. https://
doi.org/10.3390/ijms222312932
Langenskiöld M, Ivarsson M-L, Holmdahl L, Falk P, Kåbjörn-Gustafsson C, Angenete E (2013)
Intestinal mucosal MMP-1 – a prognostic factor in colon cancer. Scand J Gastroenterol
48:563–569. https://doi.org/10.3109/00365521.2012.708939
Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A (2018) The multiple layers of the tumor
environment. Trends Cancer 4:802–809. https://doi.org/10.1016/j.trecan.2018.10.002
Larsson LI, Fahrenkrug J, Schaffalitzky De Muckadell O, Sundler F, Håkanson R, Rehfeld JR
(1976) Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.
Proc Natl Acad Sci U S A 73:3197–3200. https://doi.org/10.1073/pnas.73.9.3197
Lelièvre V, Meunier AC, Caigneaux E, Falcon J, Muller JM (1998) Differential expression and
function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. Cell
Signal 10:13–26. https://doi.org/10.1016/s0898-6568(97)00067-3
Lesurtel M, Soll C, Graf R, Clavien P-A (2008) Role of serotonin in the hepato-gastroIntestinal
tract: an old molecule for new perspectives. Cell Mol Life Sci 65:940–952. https://doi.org/
10.1007/s00018-007-7377-3
Levy A, Gal R, Granoth R, Dreznik Z, Fridkin M, Gozes I (2002) In vitro and in vivo treatment of
colon cancer by VIP antagonists. Regul Pept 109:127–133. https://doi.org/10.1016/s0167-0115
(02)00195-7
Li ZJ, Cho CH (2011) Neurotransmitters, more than meets the eye–neurotransmitters and their
perspectives in cancer development and therapy. Eur J Pharmacol 667:17–22. https://doi.org/
10.1016/j.ejphar.2011.05.077
Li Y, Chen S, Li Z (1998) Plasma neuropeptide Y (NPY) levels in patients with gastric and
colorectal carcinomas. Zhonghua Zhong Liu Za Zhi 20:213–215
Lien Y-C, Wang W, Kuo L-J, Liu J-J, Wei P-L, Ho Y-S, Ting W-C, Wu C-H, Chang Y-J (2011)
Nicotine promotes cell migration through alpha7 nicotinic acetylcholine receptor in gastric
cancer cells. Ann Surg Oncol 18:2671–2679. https://doi.org/10.1245/s10434-011-1598-2
Lin Z, Natesan V, Shi H, Dong F, Kawanami D, Mahabeleshwar GH, Atkins GB, Nayak L, Cui Y,
Finigan JH, Jain MK (2010) Kruppel-like factor 2 regulates endothelial barrier function.
Arterioscler Thromb Vasc Biol 30:1952–1959. https://doi.org/10.1161/ATVBAHA.110.
211474
Role of Neuromodulators in Regulation of the Tumor Microenvironment.. . 179
https://t.me/med1917
Lin H, Huang H, Yu Y, Chen W, Zhang S, Zhang Y (2021) Nerve growth factor regulates liver
cancer cell polarity and motility. Mol Med Rep 23:288. https://doi.org/10.3892/mmr.2021.
11927
Liu S, Zeng Y, Li Y, Guo W, Liu J, Ouyang N (2014) VPAC1 overexpression is associated with
poor differentiation in colon cancer. Tumour Biol 35:6397–6404. https://doi.org/10.1007/
s13277-014-1852-x
Liu J, Deng G-H, Zhang J, Wang Y, Xia X-Y, Luo X-M, Deng Y-T, He S-S, Mao Y-Y, Peng X-C,
Wei Y-Q, Jiang Y (2015) The effect of chronic stress on anti-angiogenesis of sunitinib in
colorectal cancer models. Psychoneuroendocrinology 52:130–142. https://doi.org/10.1016/j.
psyneuen.2014.11.008
Lomax AE, Sharkey KA, Furness JB (2009) The participation of the sympathetic innervation of the
gastrointestinal tract in disease states. Neurogastroenterol Motil. https://doi.org/10.1111/j.
1365-2982.2009.01381.x
Lummis SCR (2012) 5-HT(3) receptors. J Biol Chem 287:40239–40245. https://doi.org/10.1074/
jbc.R112.406496
Maemura K, Shiraishi N, Sakagami K, Kawakami K, Inoue T, Murano M, Watanabe M, Otsuki Y
(2009) Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are
associated with extracellular signal-regulated kinase 1/2 activation. J Gastroenterol Hepatol
24:688–696. https://doi.org/10.1111/j.1440-1746.2008.05687.x
Maggi CA, Catalioto RM, Criscuoli M, Cucchi P, Giuliani S, Lecci A, Lippi A, Meini S,
Patacchini R, Renzetti AR, Santicioli P, Tramontana M, Zagorodnyuk V, Giachetti A (1997)
Tachykinin receptors and intestinal motility. Can J Physiol Pharmacol 75:696–703
Mangiola S, McCoy P, Modrak M, Souza-Fonseca-Guimaraes F, Blashki D, Stuchbery R, Keam
SP, Kerger M, Chow K, Nasa C, Le Page M, Lister N, Monard S, Peters J, Dundee P, Williams
SG, Costello AJ, Neeson PJ, Pal B, Huntington ND, Corcoran NM, Papenfuss AT, Hovens CM
(2021) Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment
reveals a dominant role for monocytic cells in progression. BMC Cancer 21:846. https://doi.org/
10.1186/s12885-021-08529-6
Matuszek M, Jesipowicz M, Kleinrok Z (2001) GABA content and GAD activity in gastric cancer.
Med Sci Monit 7:377–381
Mawe GM, Hoffman JM (2013) Serotonin signalling in the gut–functions, dysfunctions and
therapeutic targets. Nat Rev Gastroenterol Hepatol 10:473–486. https://doi.org/10.1038/
nrgastro.2013.105
Mayordomo C, García-Recio S, Ametller E, Fernández-Nogueira P, Pastor-Arroyo EM, Vinyals L,
Casas I, Gascón P, Almendro V (2012) Targeting of substance P induces cancer cell death and
decreases the steady state of EGFR and Her2. J Cell Physiol 227:1358–1366. https://doi.org/
10.1002/jcp.22848
McConalogue K, Furness JB (1994) Gastrointestinal neurotransmitters. Bailliere Clin Endocrinol
Metab 8:51–76. https://doi.org/10.1016/s0950-351x(05)80226-5
Mehedințeanu AM, Sfredel V, Stovicek PO, Schenker M, Târtea GC, Istrătoaie O, Ciurea A-M,
Vere CC (2021) Assessment of epinephrine and norepinephrine in gastric carcinoma. Int J Mol
Sci 22:2042. https://doi.org/10.3390/ijms22042042
Mercuri NB, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernardi G, Borrelli E (1997) Loss of
autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice.
Neuroscience 79:323–327. https://doi.org/10.1016/s0306-4522(97)00135-8
Mezey E, Eisenhofer G, Hansson S, Hunyady B, Hoffman BJ (1998) Dopamine produced by the
stomach may act as a paracrine/autocrine hormone in the rat. Neuroendocrinology 67:336–348.
https://doi.org/10.1159/000054332
Mezey E, Eisenhofer G, Hansson S, Harta G, Hoffman BJ, Gallatz K, Palkovits M, Hunyady B
(1999) Non-neuronal dopamine in the gastrointestinal system. Clin Exp Pharmacol Physiol
Suppl 26:S14–S22
Millar NS (2003) Assembly and subunit diversity of nicotinic acetylcholine receptors. Biochem Soc
Trans 31:869–874. https://doi.org/10.1042/bst0310869
180 D. Chakroborty and C. Sarkar
https://t.me/med1917
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure
to function. Physiol Rev 78:189–225. https://doi.org/10.1152/physrev.1998.78.1.189
Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O’Connor G, Grati M, Mittal J, Yan D, Eshraghi
AA, Deo SK, Daunert S, Liu XZ (2017) Neurotransmitters: the critical modulators regulating
gut-brain Axis. J Cell Physiol 232:2359–2372. https://doi.org/10.1002/jcp.25518
Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A (1996) Nitric oxide synthase
activity and expression in human colorectal cancer. Carcinogenesis 17:1171–1174. https://doi.
org/10.1093/carcin/17.5.1171
Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in
pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000.
https://doi.org/10.1016/S0002-9440(10)64920-6
Mou X-Z, Chen X, Ru G, Ma Y, Xie J, Chen W, Wang H, Wang S-B, Li L, Jin K, He X (2016) High
expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is
associated with tumor progression and prognosis. Onco Targets Ther 9:3595. https://doi.org/
10.2147/OTT.S102356
Mravec B, Horvathova L, Hunakova L (2020) Neurobiology of cancer: the role of β-adrenergic
receptor signaling in various tumor environments. Int J Mol Sci 21:E7958. https://doi.org/
10.3390/ijms21217958
Murray GI, Duncan ME, O’Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinase–1is
associated with poor prognosis in colorectal cancer. Nat Med 2:461–462. https://doi.org/
10.1038/nm0496-461
Nagy JA, Chang S-H, Dvorak AM, Dvorak HF (2009) Why are tumour blood vessels abnormal and
why is it important to know? Br J Cancer 100:865–869. https://doi.org/10.1038/sj.bjc.6604929
Nagy JA, Chang S-H, Shih S-C, Dvorak AM, Dvorak HF (2010) Heterogeneity of the tumor
vasculature. Semin Thromb Hemost 36:321–331. https://doi.org/10.1055/s-0030-1253454
Nam KT, Oh S-Y, Ahn B, Kim YB, Jang DD, Yang K-H, Hahm K-B, Kim D-Y (2004) Decreased
Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide
synthase. Gut 53:1250–1255. https://doi.org/10.1136/gut.2003.030684
Nardone G (2003) Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol
Ther 17(Suppl 2):75–81. https://doi.org/10.1046/j.1365-2036.17.s2.10.x
Niu G, Deng L, Zhang X, Hu Z, Han S, Xu K, Hong R, Meng H, Ke C (2020) GABRD promotes
progression and predicts poor prognosis in colorectal cancer. Open Med 15:1172–1183. https://
doi.org/10.1515/med-2020-0128
Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Graf R, Clavien P-A (2008)
Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer
allografts. Cancer Res 68:5152–5158. https://doi.org/10.1158/0008-5472.CAN-08-0202
Ogasawara M, Murata J, Ayukawa K, Saimi I (1997) Differential effect of intestinal neuropeptides
on invasion and migration of colon carcinoma cells in vitro. Cancer Lett 116:111–116. https://
doi.org/10.1016/s0304-3835(97)00167-5
Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and
pharmacology. Neuropharmacology 56:141–148. https://doi.org/10.1016/j.neuropharm.2008.
07.045
Ozdemir V, Bertilsson L, Miura J, Carpenter E, Reist C, Harper P, Widén J, Svensson J-O, Albers
LJ, Kennedy JL, Endrenyi L, Kalow W (2007) CYP2D6 genotype in relation to perphenazine
concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-
dopamine crosstalk revisited. Pharmacogenet Genomics 17:339–347. https://doi.org/10.1097/
FPC.0b013e32801a3c10
Pan C, Wu J, Zheng S, Sun H, Fang Y, Huang Z, Shi M, Liang L, Bin J, Liao Y, Chen J, Liao W
(2021) Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendo-
crine phenotype via the catecholamine/β2 -AR/MACC1 axis. Cancer Commun (Lond)
41:1049–1070. https://doi.org/10.1002/cac2.12198
Pedrosa L, Esposito F, Thomson TM, Maurel J (2019) The tumor microenvironment in colorectal
cancer therapy. Cancers (Basel) 11:E1172. https://doi.org/10.3390/cancers11081172
Role of Neuromodulators in Regulation of the Tumor Microenvironment.. . 181
https://t.me/med1917
Pernow B (1983) Substance P. Pharmacol Rev 35:85–141
Peters MAM, Walenkamp AME, Kema IP, Meijer C, de Vries EGE, Oosting SF (2014) Dopamine
and serotonin regulate tumor behavior by affecting angiogenesis. Drug Resist Updat 17:96–104.
https://doi.org/10.1016/j.drup.2014.09.001
Phillips RJ, Powley TL (2007) Innervation of the gastrointestinal tract: patterns of aging. Auton
Neurosci 136:1–19. https://doi.org/10.1016/j.autneu.2007.04.005
Pu J, Bai D, Yang X, Lu X, Xu L, Lu J (2012) Adrenaline promotes cell proliferation and increases
chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem Biophys
Res Commun 428(2):210–215. https://doi.org/10.1016/j.bbrc.2012.09.126. Epub 2012 Oct 1.
PMID: 23036199
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis.
Nat Med 19:1423–1437. https://doi.org/10.1038/nm.3394
Rademakers G, Vaes N, Schonkeren S, Koch A, Sharkey KA, Melotte V (2017) The role of enteric
neurons in the development and progression of colorectal cancer. Biochim Biophys Acta Rev
Cancer 1868:420–434. https://doi.org/10.1016/j.bbcan.2017.08.003
Rao M, Gershon MD (2018) Enteric nervous system development: what could possibly go wrong?
Nat Rev Neurosci 19:552–565. https://doi.org/10.1038/s41583-018-0041-0
Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R,
O’neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG,
Stricker PD, Sutherland RL, Henshall SM (2006) Aberrant neuropeptide Y and macrophage
inhibitory cytokine-1 expression are early events in prostate cancer development and are
associated with poor prognosis. Cancer Epidemiol Biomark Prev 15:711–716. https://doi.org/
10.1158/1055-9965.EPI-05-0752
Regoli D, Boudon A, Fauchére JL (1994) Receptors and antagonists for substance P and related
peptides. Pharmacol Rev 46:551–599
Rettenbacher M, Reubi JC (2001) Localization and characterization of neuropeptide receptors in
human colon. Naunyn Schmiedeberg’s Arch Pharmacol 364:291–304. https://doi.org/10.1007/
s002100100454
Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000) Vasoactive
intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human
tumors and their tissues of origin. Cancer Res 60:3105–3112
Reubi JC, Gugger M, Waser B, Schaer JC (2001) Y(1)-mediated effect of neuropeptide Y in cancer:
breast carcinomas as targets. Cancer Res 61:4636–4641
Romero-López M, Trinh AL, Sobrino A, Hatch MMS, Keating MT, Fimbres C, Lewis DE, Gershon
PD, Botvinick EL, Digman M, Lowengrub JS, Hughes CCW (2017) Recapitulating the human
tumor microenvironment: colon tumor-derived extracellular matrix promotes angiogenesis and
tumor cell growth. Biomaterials 116:118–129. https://doi.org/10.1016/j.biomaterials.2016.
11.034
Rosso M, Robles-Frías MJ, Coveñas R, Salinas-Martín MV, Muñoz M (2008) The NK-1 receptor is
expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor
action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer
cell lines. Tumour Biol 29:245–254. https://doi.org/10.1159/000152942
Rubí B, Maechler P (2010) Minireview: new roles for peripheral dopamine on metabolic control
and tumor growth: let’s seek the balance. Endocrinology 151:5570–5581. https://doi.org/10.
1210/en.2010-0745
Rueda Ruzafa L, Cedillo JL, Hone AJ (2021) Nicotinic acetylcholine receptor involvement in
inflammatory bowel disease and interactions with gut microbiota. Int J Environ Res Public
Health 18:1189. https://doi.org/10.3390/ijerph18031189
Sakita JY, Bader M, Santos ES, Garcia SB, Minto SB, Alenina N, Brunaldi MO, Carvalho MC,
Vidotto T, Gasparotto B, Martins RB, Silva WA, Brandão ML, Leite CA, Cunha FQ,
Karsenty G, Squire JA, Uyemura SA, Kannen V (2019) Serotonin synthesis protects the
mouse colonic crypt from DNA damage and colorectal tumorigenesis. J Pathol 249:102–113.
https://doi.org/10.1002/path.5285
182 D. Chakroborty and C. Sarkar
https://t.me/med1917
Sarkar C, Chakroborty D (2014) Neuropeptide Y as a prognostic marker of colorectal cancer.
Cancer Res 74(19_Supplement):5354–5354
Sarkar C, Chakroborty D, Chowdhury UR, Dasgupta PS, Basu S (2008) Dopamine increases the
efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res
14:2502–2510. https://doi.org/10.1158/1078-0432.CCR-07-1778
Sarkar C, Chakroborty D, Basu S (2013) Neurotransmitters as regulators of tumor angiogenesis and
immunity: the role of catecholamines. J Neuroimmune Pharmacol 8:7–14. https://doi.org/
10.1007/s11481-012-9395-7
Sarkar C, Chakroborty D, Goswami S, Fan H, Mo X, Basu S (2022) VEGF-A controls the
expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial
cells. J Cell Sci 135:jcs259617. https://doi.org/10.1242/jcs.259617
Schledwitz A, Xie G, Raufman J-P (2021) Exploiting unique features of the gut-brain interface to
combat gastrointestinal cancer. J Clin Invest 131:143776. https://doi.org/10.1172/JCI143776
Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K,
Ungethüm U, Kobold S, Graf R, van den Broek M, Vom Berg J, Gupta A, Clavien P-A
(2021) Attenuation of peripheral serotonin inhibits tumor growth and enhances immune check-
point blockade therapy in murine tumor models. Sci Transl Med 13:eabc8188. https://doi.org/
10.1126/scitranslmed.abc8188
Scott DJ, Hull MA, Cartwright EJ, Lam WK, Tisbury A, Poulsom R, Markham AF, Bonifer C,
Coletta PL (2001) Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in
the Apc(Min/+) mouse. Gastroenterology 121:889–899. https://doi.org/10.1053/gast.2001.
27994
Sejda A, Sigorski D, Gulczyński J, Wesołowski W, Kitlińska J, Iżycka-Świeszewska E (2020)
Complexity of neural component of tumor microenvironment in prostate cancer. Pathobiology
87:87–99. https://doi.org/10.1159/000505437
Shah PA, Park CJ, Shaughnessy MP, Cowles RA (2021) Serotonin as a mitogen in the gastrointes-
tinal tract: revisiting a familiar molecule in a new role. Cell Mol Gastroenterol Hepatol
12:1093–1104. https://doi.org/10.1016/j.jcmgh.2021.05.008
Shan T, Cui X, Li W, Lin W, Li Y, Chen X, Wu T (2014) Novel regulatory program for
norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell
lines. Cancer Sci 105:847–856. https://doi.org/10.1111/cas.12438
Shang J, Pena AS (2005) Multidisciplinary approach to understand the pathogenesis of gastric
cancer. World J Gastroenterol 11(27):4131–4139. https://doi.org/10.3748/wjg.v11.i27.
4131. PMID: 16015679; PMCID: PMC4615432
Shi M, Liu D, Duan H, Han C, Wei B, Qian L, Chen C, Guo L, Hu M, Yu M, Song L, Shen B, Guo
N (2010) Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in
gastric cancer. Mol Cancer 9:269. https://doi.org/10.1186/1476-4598-9-269
Shi M, Yang Z, Hu M, Liu D, Hu Y, Qian L, Zhang W, Chen H, Guo L, Yu M, Song L, Ma Y,
Guo N (2013) Catecholamine-Induced β2-adrenergic receptor activation mediates desensitiza-
tion of gastric cancer cells to trastuzumab by upregulating MUC4 expression. J Immunol
190:5600–5608. https://doi.org/10.4049/jimmunol.1202364
Shin VY, Wu WKK, Chu K-M, Wong HPS, Lam EKY, Tai EKK, Koo MWL, Cho C-H (2005)
Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in associ-
ation with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res
3:607–615. https://doi.org/10.1158/1541-7786.MCR-05-0106
Shin VY, Jin HC, Ng EKO, Yu J, Leung WK, Cho CH, Sung JJY (2008) Nicotine and
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human
gastric cancer cells: involvement of nicotinic acetylcholine receptor (nAChR) and beta-
adrenergic receptor signaling pathways. Toxicol Appl Pharmacol 233:254 –261. https://doi.
org/10.1016/j.taap.2008.08.012
Siebenhüner AR, De Dosso S, Helbling D, Astaras C, Szturz P, Moosmann P, Pederiva S,
Winder T, Von Burg P, Borner M (2021) Advanced gastric cancer: current treatment landscape
and a future outlook for sequential and personalized guide: Swiss expert statement article. Oncol
Res Treat 44:485
–494. https://doi.org/10.1159/000518107
Role of Neuromodulators in Regulation of the Tumor Microenvironment.. . 183
https://t.me/med1917
Smith RA, Fedewa S, Siegel R (2021) Early colorectal cancer detection-current and evolving
challenges in evidence, guidelines, policy, and practices. Adv Cancer Res 151:69–107.
https://doi.org/10.1016/bs.acr.2021.03.005
Smyth MJ, Ngiow SF, Ribas A, Teng MWL (2016) Combination cancer immunotherapies tailored
to the tumour microenvironment. Nat Rev Clin Oncol 13:143–158. https://doi.org/10.1038/
nrclinonc.2015.209
Son S-M, Woo CG, Kim DH, Yun HY, Kim H, Kim HK, Yang Y, Kwon J, Kwon M, Kim T-Y,
Kim H-D, Koh J-Y, Park S-H, Shin E-C, Han HS (2020) Distinct tumor immune
microenvironments in primary and metastatic lesions in gastric cancer patients. Sci Rep
10:14293. https://doi.org/10.1038/s41598-020-71340-z
Song Z-J, Gong P, Wu Y-E (2002) Relationship between the expression of iNOS,VEGF,tumor
angiogenesis and gastric cancer. World J Gastroenterol 8:591–595. https://doi.org/10.3748/wjg.
v8.i4.591
Spindel ER (2012) Muscarinic receptor agonists and antagonists: effects on cancer. Handb Exp
Pharmacol:451–468. https://doi.org/10.1007/978-3-642-23274-9_19
Strasser B, Gostner JM, Fuchs D (2016) Mood, food, and cognition: role of tryptophan and
serotonin. Curr Opin Clin Nutr Metab Care 19:55–61. https://doi.org/10.1097/MCO.
0000000000000237
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global
cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Szabo S (1979) Dopamine disorder in duodenal ulceration. Lancet 2:880–882. https://doi.org/
10.1016/s0140-6736(79)92690-4
Tang B, Wu J, Zhu MX, Sun X, Liu J, Xie R, Dong TX, Xiao Y, Carethers JM, Yang S, Dong H
(2019) VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer
progression via a novel autocrine mechanism. Oncogene 38:3946–3961. https://doi.org/
10.1038/s41388-019-0709-6
Tank AW, Lee Wong D (2015) Peripheral and central effects of circulating catecholamines. Compr
Physiol 5:1–15. https://doi.org/10.1002/cphy.c140007
Tatsuta M, Iishi H, Baba M, Nakaizumi A, Ichii M, Taniguchi H (1990) Inhibition by gamma-
amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-methyl-N’-nitro-N-
nitrosoguanidine in Wistar rats. Cancer Res 50:4931–4934
Tatsuta M, Iishi H, Baba M, Taniguchi H (1992) Attenuation by the GABA receptor agonist
baclofen of experimental carcinogenesis in rat colon by azoxymethane. Oncology
49:241–245. https://doi.org/10.1159/000227048
Tatsuta M, Iishi H, Baba M, Yano H, Iseki K, Uehara H, Nakaizumi A (1995) Promotion by
substance P of gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in
Wistar rats. Cancer Lett 96:99–103. https://doi.org/10.1016/0304-3835(95)03917-l
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H, Porta-Pardo E, Gao GF,
Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R,
Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V,
Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y,
Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS,
Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J,
Saltz J, Holt RA, Rabkin CS, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS,
Demicco EG, Disis ML, Vincent BG, Shmulevich I (2018) The immune landscape of cancer.
Immunity 48:812–830.e14. https://doi.org/10.1016/j.immuni.2018.03.023
Torashima Y, Uezono Y, Kanaide M, Ando Y, Enjoji A, Kanematsu T, Taniyama K (2009)
Presence of GABA(B) receptors forming heterodimers with GABA(B1) and GABA
(B2) subunits in human lower esophageal sphincter. J Pharmacol Sci 111:253–259. https://
doi.org/10.1254/jphs.09062fp
184 D. Chakroborty and C. Sarkar
https://t.me/med1917
Tu C-C, Huang C-Y, Cheng W-L, Hung C-S, Chang Y-J, Wei P-L (2016a) Silencing A7-nAChR
levels increases the sensitivity of gastric cancer cells to ixabepilone treatment. Tumour Biol
37:9493–9501. https://doi.org/10.1007/s13277-015-4751-x
Tu C-C, Huang C-Y, Cheng W-L, Hung C-S, Uyanga B, Wei P-L, Chang Y-J (2016b) The
α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes.
Tumour Biol 37:4421–4428. https://doi.org/10.1007/s13277-015-4260-y
Tutton PJM, Barkla DH (1978) The influence of serotonin on the mitotic rate in the colonic crypt
epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol 5:91–94. https://
doi.org/10.1111/j.1440-1681.1978.tb00657.x
Uesaka T, Young HM, Pachnis V, Enomoto H (2016) Development of the intrinsic and extrinsic
innervation of the gut. Dev Biol 417:158–167. https://doi.org/10.1016/j.ydbio.2016.04.016
Ugalde V, Contreras F, Prado C, Chovar O, Espinoza A, Pacheco R (2021) Dopaminergic
signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal
inflammation. Mucosal Immunol 14:652–666. https://doi.org/10.1038/s41385-020-00354-7
Vinuesa AG, Sancho R, García-Limones C, Behrens A, ten Dijke P, Calzado MA, Muñoz E (2012)
Vanilloid receptor-1 regulates neurogenic inflammation in colon and protects mice from colon
cancer. Cancer Res 72:1705–1716. https://doi.org/10.1158/0008-5472.CAN-11-3693
Wang JP, Hielscher A (2017) Fibronectin: how its aberrant expression in tumors may improve
therapeutic targeting. J Cancer 8:674–682. https://doi.org/10.7150/jca.16901
Wang L, Shi GG, Yao JC, Gong W, Wei D, Wu T-T, Ajani JA, Huang S, Xie K (2005) Expression
of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts
poor prognosis in human gastric cancer. Gastric Cancer 8:18–28. https://doi.org/10.1007/
s10120-004-0310-7
Wang W, Chin-Sheng H, Kuo L-J, Wei P-L, Lien Y-C, Lin F-Y, Liu H-H, Ho Y-S, Wu C-H, Chang
Y-J (2012) NNK enhances cell migration through α7-nicotinic acetylcholine receptor
accompanied by increased of fibronectin expression in gastric cancer. Ann Surg Oncol
19:580–588. https://doi.org/10.1245/s10434-011-2064-x
Wang L, Zhi X, Zhang Q, Wei S, Li Z, Zhou J, Jiang J, Zhu Y, Yang L, Xu H, Xu Z (2016)
Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to
apoptosis in gastric cancer. Tumour Biol 37:2105–2117. https://doi.org/10.1007/s13277-015-
4011-0
Wang Y, Wang S, Yang Q, Li J, Yu F, Zhao E (2021) Norepinephrine enhances aerobic glycolysis
and may act as a predictive factor for immunotherapy in gastric cancer. J Immunol Res
2021:5580672. https://doi.org/10.1155/2021/5580672
Wei P-L, Chang Y-J, Ho Y-S, Lee C-H, Yang Y-Y, An J, Lin S-Y (2009) Tobacco-specific
carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine recep-
tor. Ann Surg 249:978–985. https://doi.org/10.1097/SLA.0b013e3181a6ce7e
Wei X, Chen L, Yang A, Lv Z, Xiong M, Shan C (2021) ADRB2 is a potential protective gene
in breast cancer by regulating tumor immune microenvironment. Transl Cancer Res
10:5280–5294. https://doi.org/10.21037/tcr-21-1257
Wong HPS, Yu L, Lam EKY, Tai EKK, Wu WKK, Cho CH (2007) Nicotine promotes cell
proliferation via α7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-
mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol
221:261–267. https://doi.org/10.1016/j.taap.2007.04.002
Wong HPS, Ho JWC, Koo MWL, Yu L, Wu WKK, Lam EKY, Tai EKK, Ko JKS, Shin VY, Chu
KM, Cho CH (2011) Effects of adrenaline in human colon adenocarcinoma HT-29 cells. Life
Sci 88:1108–1112. https://doi.org/10.1016/j.lfs.2011.04.007
Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, Teoh A, Liang P (2021) Global
incidence and mortality of gastric cancer, 1980-2018. JAMA Netw Open 4:e2118457. https://
doi.org/10.1001/jamanetworkopen.2021.18457
Wu Z, Cheng H, Jiang Y, Melcher K, Xu HE (2015) Ion channels gated by acetylcholine and
serotonin: structures, biology, and drug discovery. Acta Pharmacol Sin 36:895–907. https://doi.
org/10.1038/aps.2015.66
Соседние файлы в папке Библиотека им академика М.И. Перельмана